Learn more Urine Iodine Gain insight into thyroid function, immune health, and breast tissue integrity with the Iodine Urine test
Sustained Weight Loss : Studies have shown that individuals who use Semaglutide in conjunction with a healthy diet and exercise plan experience significant, sustainable weight loss
Board-certified obesity medicine physician
The term neuroprotection is widely employed across preclinical and clinical contexts, but it lacks a clear, universally accepted operational definition
Transfer to a bowl and serve slightly warm or at room temperature
What's New: July 2026 Update TRIUMPH-4 confirmed: Retatrutide 28.7% weight loss in Phase 3 (December 2025) final data, not preliminary TRIUMPH-1 CONFIRMED (May 21, 2026): 28.3% average weight loss at 80 weeks in 2,339 patients without diabetes pivotal trial met all primary endpoints Availability unchanged: Retatrutide still investigational, no FDA approval until late 2027 at earliest Tirzepatide still the best available option: 22.5% weight loss, FDA-approved, available today TRANSCEND-T2D-1 confirmed (June 2026): -2.0% HbA1c and 16.8% weight loss in type 2 diabetes patients a separate diabetes-specific Phase 3 program NDA timeline on track: industry estimates continue to expect Q4 2026 filing, following TRIUMPH-1's positive readout Introduction The evolution of weight loss medications has progressed rapidly from single-agonist drugs to multi-agonist approaches
